RNF34 antibody

Synonyms:E3 ubiquitin-protein ligase RNF34|Caspase regulator CARP1|Caspases-8 and -10-associated RING finger protein 1 (CARP-1)|FYVE-RING finger protein Momo|Human RING finger homologous to inhibitor of apoptosis protein (hRFI)|RING finger protein 34|RING finger protein RIFF|RING-type E3 ubiquitin transferase RNF34|RNF34 antibody
Catalogue No.:FNab10144Reactivity:Human
Host:RabbitTested Application:WB
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
RNF34 antibody
Catalogue No.
FNab10144
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
ring finger protein 34
Alternative Names
E3 ubiquitin-protein ligase RNF34|Caspase regulator CARP1|Caspases-8 and -10-associated RING finger protein 1 (CARP-1)|FYVE-RING finger protein Momo|Human RING finger homologous to inhibitor of apoptosis protein (hRFI)|RING finger protein 34|RING finger protein RIFF|RING-type E3 ubiquitin transferase RNF34|RNF34 antibody
UniProt ID
Q969K3
Observed MW
41 kDa
Application
Tested Applications
WB
Recommended dilution
WB: 1:200-1:2000
Validated Images
Hela cells were subjected to SDS PAGE followed by western blot with FNab10144(RNF34 antibody) at dilution of 1:1000
Background
E3 ubiquitin-protein ligase that regulates several biological processes through the ubiquitin-mediated proteasomal degradation of various target proteins. Ubiquitinates the caspases CASP8 and CASP10, promoting their proteasomal degradation, to negatively regulate cell death downstream of death domain receptors in the extrinsic pathway of apoptosis(PubMed:15069192). May mediate 'Lys-48'-linked polyubiquitination of RIPK1 and its subsequent proteasomal degradation thereby indirectly regulating the tumor necrosis factor-mediated signaling pathway(Ref.13). Negatively regulates p53/TP53 through its direct ubiquitination and targeting to proteasomal degradation(PubMed:17121812). Indirectly, may also negatively regulate p53/TP53 through ubiquitination and degradation of SFN(PubMed:18382127). Mediates PPARGC1A proteasomal degradation probably through ubiquitination thereby indirectly regulating the metabolism of brown fat cells(PubMed:22064484). Possibly involved in innate immunity, through 'Lys-48'-linked polyubiquitination of NOD1 and its subsequent proteasomal degradation(PubMed:25012219).